Author

M. Kesik-Brodacka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

D. Nayak· 1 shared J. Granda· 1 shared K. Olech· 1 shared L. Zhang· 1 shared M. Burda-Grabowska· 1 shared M. Drag· 1 shared M. Giurg· 1 shared M. Zmudzinski· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

D. Nayak

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistrybioRxivPreprintAug 30, 2020

Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases - PLpro and Mpro in in vitro studies

M. Zmudzinski, W. Rut, K. Olech…·M. Drag

This study identifies ebselen derivatives as potent inhibitors of SARS-CoV-2 proteases PLpro and Mpro in vitro, with some compounds showing greater potency than ebselen itself.

DOI 10.1101/2020.08.30.273979

experimental assaydrug response / drug discovery

𝕏 PostBluesky